Tuesday, February 15, 2022

< + > The Road To 340B Was Paved With Good Intentions So Why Are Drug Companies Looking For An Off Ramp?

From a $5 billion program in 2014 to a $30 billion program in 2019, 340B saw a 47% compound annual growth rate in five years, significantly outpacing other government pricing programs. Current estimates place it at about $34 billion today.

No comments:

Post a Comment

< + > This Week’s Health IT Jobs – June 18, 2025

It can be very overwhelming scrolling though job board after job board in search of a position that fits your wants and needs. Let us take t...